Biomedical Diagnostics to develop breast cancer test
This article was originally published in Clinica
Two companies jointly funding and developing an early diagnostic test for breast cancer have formed a commercial company to take the idea further. Biotherapies of Ann Arbor, Michigan and BioLabs, based in New York, have launched Biomedical Diagnostics, with BioLabs providing initial funding of $1.5 million. The two companies have been co-operating since the beginning of the year.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.